Related Experiment Video
Updated: Jan 7, 2026

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
Published on: June 14, 2020
Basic Science and Pathogenesis
Andrea Elia1, Rebecca M Parodi Rullan2, Rafael Vazquez-Torres3
1Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
Alzheimer's disease (AD) pathology disrupts brain-heart signaling, causing cardiac nerve damage and dysfunction. Amyloid-beta (Aβ) oligomers reduce brain-derived neurotrophic factor (BDNF) in heart cells, highlighting a new mechanism for AD-related cardiac issues.
Area of Science:
- Neuroscience
- Cardiology
- Molecular Biology
Background:
- Alzheimer's disease (AD) disrupts neurotrophic factors (NTFs), impacting neuronal health and potentially causing cardiovascular issues.
- Mechanisms linking AD pathology to impaired brain-heart axis, myocardial innervation, and function remain unclear.
Purpose of the Study:
- To investigate the impact of AD pathology on cardiac physiology and the brain-heart axis.
- To elucidate the role of amyloid-beta (Aβ) in neurotrophic factor depletion and cardiac neuronal degeneration.
Main Methods:
- Comprehensive analysis of cardiac physiology, amyloid pathology, NTF depletion, and cardiac neuronal fiber degeneration in AD mouse models, human cardiomyocytes, and human AD heart tissue.
- Assessment of Aβ oligomer effects on BDNF expression and CREB function in cardiomyocytes.
- Postmortem analysis of human left ventricular (LV) tissue from AD patients.
Main Results:
- AD pathology increases myocardial fibrosis, Aβ deposition, and brain-heart axis remodeling, leading to myocardial denervation and impaired cardiac function.
- Aβ oligomers reduce BDNF expression in human cardiomyocytes by disrupting CREB function.
- Human AD LV tissue confirmed findings from animal and cell studies.
Conclusions:
- A previously unrecognized mechanism reveals Aβ dysregulates cardiac neurotrophic signaling, contributing to cardiac degeneration in AD.
- Findings underscore the significance of cardiac complications in AD management and suggest new therapeutic avenues.
- Highlights the need to reevaluate clinical approaches to AD therapy by considering cardiac health.
Related Concept Videos
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Urinary Tract Infection II: Pathophysiology
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Pneumonia II: Pathophysiology
Stages of Infection
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

